Clearside Biomedical, Inc. (CLSD) Earnings History
Annual and quarterly earnings data from 2012 to 2024
Loading earnings history...
CLSD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CLSD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 91.0% | -1735.7% | -2064.4% |
| 2023 | 95.7% | -302.0% | -394.9% |
| 2022 | 84.6% | -2281.6% | -2482.8% |
| 2021 | 100.0% | -2.1% | 1.3% |
| 2020 | 100.0% | -227.2% | -230.7% |
Download Data
Export CLSD earnings history in CSV or JSON format
Free sign-in required to download data
Clearside Biomedical, Inc. (CLSD) Earnings Overview
As of May 8, 2026, Clearside Biomedical, Inc. (CLSD) reported trailing twelve-month net income of -$26M, reflecting +11.3% year-over-year growth. The company earned $-4.97 per diluted share over the past four quarters, with a net profit margin of -2064.4%.
Looking at the long-term picture, CLSD's historical earnings data spans multiple years. The company achieved its highest annual net income of $376,000 in fiscal 2021.
Clearside Biomedical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including OCUL (-$290M net income, -513.2% margin), ADVM (-$204M net income, -13092.7% margin), RCKT (-$223M net income), CLSD has room to improve margins relative to the peer group. Compare CLSD vs OCUL →
CLSD Earnings vs Peers
Earnings metrics vs comparable public companies
CLSD Historical Earnings Data (2012–2024)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$34M | -5.7% | -$29M | $-7.05 | -2064.4% | -1735.7% |
| 2023 | -$32M | +1.4% | -$25M | $-7.95 | -394.9% | -302.0% |
| 2022 | -$33M | -8862.5% | -$30M | $-8.25 | -2482.8% | -2281.6% |
| 2021 | $376,000 | +102.1% | $-627,000 | $0.09 | 1.3% | -2.1% |
| 2020 | -$18M | +40.8% | -$18M | $-5.85 | -230.7% | -227.2% |
| 2019 | -$31M | +62.8% | -$30M | $-12.00 | -1416.0% | -1394.6% |
| 2018 | -$83M | -40.4% | -$83M | $-40.35 | -276060.0% | -276483.3% |
| 2017 | -$59M | -127.9% | -$58M | $-34.95 | -17094.2% | -16929.9% |
| 2016 | -$26M | -46.7% | -$25M | $-29.55 | -4977.3% | -4845.8% |
| 2015 | -$18M | -73.1% | -$17M | $-21.60 | - | - |
See CLSD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLSD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLSD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCLSD — Frequently Asked Questions
Quick answers to the most common questions about buying CLSD stock.
Is CLSD growing earnings?
CLSD EPS stands at $-4.97, with +11.3% growth matching the 5-year CAGR of N/A. TTM net income is $-26M. Earnings trajectory remains consistent.
What are CLSD's profit margins?
Clearside Biomedical, Inc. net margin is -2064.4%, with operating margin at -1735.7%. Below-average margins reflect competitive or cost pressures.
How consistent are CLSD's earnings?
CLSD earnings data spans 2012-2024. The current earnings trend is +11.3% YoY. Historical data enables comparison across business cycles.